21 CFR Part 11 is a regulation by the U.S. Food and Drug Administration (FDA) that outlines the criteria for accepting electronic records and electronic signatures. It specifies requirements for the integrity, security, and availability of these records to ensure they are as trustworthy and reliable as traditional paper-based documents.